Search

everythinglearnresearchcommunity

for

Search:↓

High and low doses of prednisolone helped 62% of children with severe alopecia regrow hair with some weight gain and mild acne as side effects.

Alopecia areata management involves explaining the condition, using treatments like steroids and immunotherapy, and providing support like counseling and wigs.

Early high-dose steroid treatment helps prolong disease-free periods in severe alopecia areata.

High-dose steroid pulse therapy effectively regrows hair in severe multifocal alopecia areata.

High-dose corticosteroid treatment helped improve symptoms in a patient with Adult Onset Still Disease.

Corticosteroid pulse therapy is more effective for severe alopecia areata than combination therapy.

Platelet-rich plasma treatment is not very effective for chronic severe alopecia areata.

Individualized treatment plans are crucial for children with alopecia areata, with promising options like JAK inhibitors showing significant hair regrowth.

Alopecia Areata is an unpredictable autoimmune hair loss condition with limited and variable treatment effectiveness.

A woman with lupus had unusual symptoms like blisters, skin inflammation, and throat ulcers, which improved with steroid and dapsone treatment.

Adalimumab helped control a child's severe eye disease when other treatments failed.

A 16-year-old boy with lupus had a rare brain artery issue but fully recovered with treatment.

High-dose corticosteroids can significantly regrow hair in severe alopecia areata.

A young woman with lupus was treated with hydroxychloroquine and prednisone.

Early immunosuppressive therapy leads to favorable outcomes in Filipino lupus patients with myocarditis.

Alopecia Areata is an autoimmune hair loss condition, with various treatments showing mixed effectiveness and no guaranteed cure.

Hair loss in teenagers is hard to treat and lacks a cure, with some treatments available depending on the type of hair loss.

Hair and nails can help diagnose diseases, with nail issues often linked to skin conditions and hair loss having various causes and treatments.

The document concludes that alopecia areata is an unpredictable autoimmune hair loss condition with no cure, but various treatments exist that require personalized approaches.

Tailored treatments for alopecia areata show promising results, with pulse steroids effective for mild cases and Ritlecitinib, Dupilumab, or methotrexate and prednisone effective for severe cases.

Pulse steroid therapy for alopecia areata shows a 43% complete response rate but has a high relapse rate, especially in children.

Systemic steroids temporarily improve severe alopecia areata in children but often lead to relapse.

A patient with Satoyoshi syndrome improved with a treatment combining several medications, including carbamazepine and methotrexate.

Anifrolumab helped some lupus patients reduce steroid use, but safety concerns remain.

The document concludes that there are various treatments for different types of alopecia, but more research is needed for evidence-based treatments.

Some treatments work for common baldness, but there's less evidence for other hair loss types, and more research is needed.

Oral ritlecitinib and baricitinib are promising treatments for severe alopecia areata due to their balance of effectiveness and safety.

The document concludes that managing skin conditions during pregnancy is important and requires specialized care.

Tofacitinib was effective for severe, treatment-resistant hair loss without side effects.

An 18-year-old girl improved with treatment after being diagnosed with both Systemic Lupus Erythematosus and Celiac Disease.